Comparative Pharmacology
Head-to-head clinical analysis: MACROTEC versus NEUROLITE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MACROTEC versus NEUROLITE.
MACROTEC vs NEUROLITE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Not applicable for diagnostic use.
NEUROLITE is a sodium channel blocker that stabilizes neuronal membranes and inhibits the release of excitatory neurotransmitters, thereby reducing neuronal excitability and seizure propagation.
5 mCi (185 MBq) intravenously as a single dose for lung perfusion imaging.
300 mg orally twice daily.
None Documented
None Documented
6 hours; prolonged in renal impairment (up to 30 hours in ESRD)
Terminal half-life: 12-15 hours; steady-state reached in 2-3 days
Renal: 95% as unchanged drug; biliary/fecal: <5% as metabolites
Renal: 70% unchanged; Biliary/Fecal: 15% as metabolites; 15% other
Category C
Category C
Radiopharmaceutical
Radiopharmaceutical